about
Salinomycin as a drug for targeting human cancer stem cellsTumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomesBreast cancer stem-like cells: clinical implications and therapeutic strategiesEpithelial-mesenchymal plasticity of breast cancer stem cells: implications for metastasis and therapeutic resistanceNotch signaling in prostate cancer: a moving targetNodal expression and detection in cancer: experience and challengesDecoding the usefulness of non-coding RNAs as breast cancer markersTumor selective cytotoxic action of a thiomorpholin hydroxamate inhibitor (TMI-1) in breast cancerPre-clinical validation of a selective anti-cancer stem cell therapy for Numb-deficient human breast cancers.Anti-cancer stem cell activity of a hedgehog inhibitor GANT61 in estrogen receptor-positive breast cancer cells.Prolyl isomerase Pin1 acts downstream of miR200c to promote cancer stem-like cell traits in breast cancerDownregulation of Bmi1 in breast cancer stem cells suppresses tumor growth and proliferation.An integrin β₃-KRAS-RalB complex drives tumour stemness and resistance to EGFR inhibition.Breast cancer stem cells rely on fermentative glycolysis and are sensitive to 2-deoxyglucose treatment.Suppression of apoptosis inhibitor c-FLIP selectively eliminates breast cancer stem cell activity in response to the anti-cancer agent, TRAIL.Using SV119-gold nanocage conjugates to eradicate cancer stem cells through a combination of photothermal and chemo therapies.Transient mTOR inhibition facilitates continuous growth of liver tumors by modulating the maintenance of CD133+ cell populations.Homogeneous datasets of triple negative breast cancers enable the identification of novel prognostic and predictive signatures.MicroRNA93 regulates proliferation and differentiation of normal and malignant breast stem cells.Unsupervised deconvolution of dynamic imaging reveals intratumor vascular heterogeneity and repopulation dynamics.Induced cancer stem-like cells as a model for biological screening and discovery of agents targeting phenotypic traits of cancer stem cell.Determining duration of HER2-targeted therapy using stem cell extinction models.Peroxisome proliferator activated receptor-α/hypoxia inducible factor-1α interplay sustains carbonic anhydrase IX and apoliprotein E expression in breast cancer stem cells.A role of TGFß1 dependent 14-3-3σ phosphorylation at Ser69 and Ser74 in the regulation of gene transcription, stemness and radioresistanceWnt/catenin signaling in adult stem cell physiology and disease.The role of radiotherapy-resistant stem cells in breast cancer recurrence.Targeting breast cancer stem cells: fishing season open!Disulfiram modulated ROS-MAPK and NFκB pathways and targeted breast cancer cells with cancer stem cell-like propertiesThe role of breast cancer stem cells in metastasis and therapeutic implications.Loss of CLCA4 promotes epithelial-to-mesenchymal transition in breast cancer cellsTargeting colon cancer stem cells using a new curcumin analogue, GO-Y030.The role of non-coding RNAs in the regulation of stem cells and progenitors in the normal mammary gland and in breast tumors.Gd-metallofullerenol nanomaterial as non-toxic breast cancer stem cell-specific inhibitorMicroRNA100 inhibits self-renewal of breast cancer stem-like cells and breast tumor developmentUpregulation of VEGF-A and CD24 gene expression by the tGLI1 transcription factor contributes to the aggressive behavior of breast cancer cells.Investigating breast cancer cell behavior using tissue engineering scaffolds.Targeting ALDH(bright) human carcinoma-initiating cells with ALDH1A1-specific CD8⁺ T cells.Leptin deficiency suppresses MMTV-Wnt-1 mammary tumor growth in obese mice and abrogates tumor initiating cell survival.In vitro and in vivo antiproliferative activity of metformin on stem-like cells isolated from spontaneous canine mammary carcinomas: translational implications for human tumorsCan CD44+/CD24- Tumor Cells Be Used to Determine the Extent of Breast Cancer Invasion Following Neoadjuvant Chemotherapy?
P2860
Q21285139-7F093CFC-C278-4100-89F5-5C352547454CQ24630783-1FAA085A-6C37-4BE5-8B1A-C1DC31B39C6AQ26752170-A19E4C7F-44B5-421A-AE81-4F87429752B1Q26824386-F848074D-7B5A-4F86-908E-91D21B62374AQ27001047-E83CF9A0-6857-493C-989B-90A6D5BF17B1Q27024576-5D188160-538F-41AD-BCB4-2B327E3CE604Q28069370-E72C64EE-4DEA-42F3-A3F7-A307CDE7D0AFQ28483867-3590C924-5C16-46E5-BEA6-CCE0D9202E3DQ33626025-5CAC8782-769A-4227-A611-EFB4D2D911EAQ33738915-5804BCF7-66A2-411B-A26E-37EA0AB907BEQ33838491-35E520A6-5A63-476C-A810-88DE129E8EBDQ33888935-B634AEBA-A036-4F03-BA2D-067BF9F8A364Q33926952-1083F6B5-DE1D-415D-B611-E3F67D3605A2Q34007740-BA122E87-A50F-4D3D-A160-0836A1DBA731Q34018500-B4A61D3D-6EE7-4B9C-9AF6-67A0D3C687CFQ34052669-0F254173-BE31-4E0B-96AE-CA8DCBFC1271Q34092485-64783362-ECCB-4F27-8753-1DFD9D10EA8EQ34119025-489DEB94-7ACF-405F-B7B8-78E96F2A75A8Q34299430-33F5B214-A159-4D7B-9583-4E8F0301EE27Q34473011-235295FC-856E-4CE3-AA85-8E1C981C23FAQ34483726-61A251B7-0960-41EE-A627-3BA25BF4A2B2Q34531367-32AC5C85-9B9D-435B-957E-B3AA431CE868Q34571496-20ED930C-9FC4-4B65-9E22-228F29138665Q34761291-51DC6B20-19B0-4E73-87C0-AC3D87461965Q34959673-76A2547E-0334-48E9-860F-D27A8639D424Q34972167-850CA75C-A0A6-438C-B415-E12CC981DE23Q34989003-B8E7D261-99F1-4399-9167-15AB5D2BCF33Q35006770-BF67D821-FB7D-4E54-AB9B-12AA70A67F10Q35070157-9159D7F4-187E-4FC4-8CB5-4829BCEF624DQ35080755-8C543833-48C2-435F-B8C8-2F5B3CA0DAE3Q35125616-18F38E8F-D5C0-47DE-81AA-DA6156AF796CQ35128540-22710154-15FD-4D48-9AFD-0DA541408826Q35160410-E216347E-3200-4358-94BD-04C73DD42008Q35207545-4DFF1B5E-B233-4D65-B69B-9B93C2B63CBAQ35219125-8542F12F-248F-4EBD-B212-C5D58392FCC5Q35250316-0AD1005F-1DAB-4206-8B34-60FBDC34973CQ35269551-8AD372CD-244C-493E-89D1-B871110C9E2BQ35399575-6C34352D-CA90-4275-AA10-8145AB36158DQ35425337-86FE86B9-F0BE-473E-8C1E-E0A634989DD6Q35435424-766BCA0B-31FC-40AD-A696-510E0BDA71A9
P2860
description
im September 2010 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована у вересні 2010
@uk
name
Targeting breast cancer stem cells
@en
Targeting breast cancer stem cells
@nl
type
label
Targeting breast cancer stem cells
@en
Targeting breast cancer stem cells
@nl
prefLabel
Targeting breast cancer stem cells
@en
Targeting breast cancer stem cells
@nl
P2860
P356
P1476
Targeting breast cancer stem cells
@en
P2093
Max S Wicha
Suling Liu
P2860
P304
P356
10.1200/JCO.2009.27.5388
P407
P577
2010-09-01T00:00:00Z